NCT03865940View on ClinicalTrials.gov

Efficacy of Guanfacine and Lidocaine Combination in Trigeminal Nerve Block for Pain Management in Trigeminal Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

October 4, 2023

Study Completion Date

January 31, 2024

Conditions
Trigeminal Neuralgia
Interventions
DRUG

Lidocaine

6 mL of 1% lidocaine

DRUG

Guanfacine

250 mcg

Trial Locations (1)

37203

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03865940 - Efficacy of Guanfacine and Lidocaine Combination in Trigeminal Nerve Block for Pain Management in Trigeminal Neuropathy | Biotech Hunter | Biotech Hunter